Health In Tech Director Receives $80K Stock Grant Under Incentive Plan

Director Sanjay Shrestha of Health In Tech received a grant of 128,474 restricted shares of Class A Common Stock at $0.62 per share on June 23, 2025, as reported in this Form 4 filing.

Rhea-AI Filing Summary

Director Sanjay Shrestha of Health In Tech received a grant of 128,474 restricted shares of Class A Common Stock at $0.62 per share on June 23, 2025, as reported in this Form 4 filing.

Key details of the stock grant:

• Shares were granted under the Health in Tech Equity Incentive Plan
• Vesting conditions include: - Full vesting after one year of service from April 8, 2025, or - Partial vesting at first shareholders' meeting based on service period ratio
• Direct ownership form of securities
• Vesting subject to continuous service requirement

This equity grant appears to be part of director compensation and aligns the director's interests with shareholders through a one-year vesting schedule.

Positive

• Director Sanjay Shrestha received 128,474 restricted shares at $0.62 per share, valued at approximately $79,654, demonstrating alignment with shareholder interests through equity-based compensation

Negative

• None.

Insider Trade Summary

Grant/Award: 128,474 shares

Grant/Award 1 txn

Insider Shrestha Sanjay K

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	128,474	$0.62	$80K

Holdings After Transaction: Class A Common Stock — 128,474 shares (Direct)

Footnotes (1)

1. F1. Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vest either (i) fully upon one year of service commencing on April 8, 2025, or (ii), if not vested upon such date, partially vest at the first shareholders' meeting, with the number of vested shares determined by multiplying the total number of restricted stock by a ratio with the numerator being the lesser of the period of time since April 8, 2025 and 12 months and the denominator being 12 months, subject to the reporting person's continuous service through the vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares of HIT stock did Director Sanjay Shrestha acquire on June 23, 2025?

Director Sanjay Shrestha acquired 128,474 shares of HIT Class A Common Stock on June 23, 2025 at a price of $0.62 per share as part of a restricted stock grant.

What is the vesting schedule for HIT Director Shrestha's restricted stock grant?

The restricted shares vest either (i) fully after one year of service from April 8, 2025, or (ii) partially at the first shareholders' meeting based on a pro-rata calculation of time served divided by 12 months, subject to continuous service through the vesting date.

What was the total value of HIT restricted stock granted to Sanjay Shrestha?

Based on the acquisition price of $0.62 per share and 128,474 shares granted, the total value of the restricted stock grant was approximately $79,654.

What position does Sanjay Shrestha hold at Health In Tech (HIT)?

According to the Form 4 filing, Sanjay Shrestha serves as a Director of Health In Tech (HIT). This is indicated by the 'X' marked in the Director box under the Relationship of Reporting Person(s) to Issuer section.

Where is HIT Director Sanjay Shrestha based?

According to the Form 4 filing, Sanjay Shrestha's address is listed as 701 S. Colorado Ave, Suite 1, Stuart, FL 34994.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/25/2025 - 09:00 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shrestha Sanjay K

(Last) (First) (Middle)

701 S. COLORADO AVE, SUITE 1

(Street)

STUART FL 34994

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Health In Tech, Inc. [ HIT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/23/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	06/23/2025		A		128,474(1)	A	$0.62	128,474	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vest either (i) fully upon one year of service commencing on April 8, 2025, or (ii), if not vested upon such date, partially vest at the first shareholders' meeting, with the number of vested shares determined by multiplying the total number of restricted stock by a ratio with the numerator being the lesser of the period of time since April 8, 2025 and 12 months and the denominator being 12 months, subject to the reporting person's continuous service through the vesting date.

	By Sanjay Shrestha /s/ Sanjay Shrestha	06/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.